Exeporfinium chloride (XF-73) nasal gel significantly reduces Staphylococcus aureus nasal carriage in cardiac surgery patients throughout surgery and the early recovery period: results from a randomized placebo-controlled Phase 2 study.
Saved in:
| Title: | Exeporfinium chloride (XF-73) nasal gel significantly reduces Staphylococcus aureus nasal carriage in cardiac surgery patients throughout surgery and the early recovery period: results from a randomized placebo-controlled Phase 2 study. |
|---|---|
| Authors: | Mangino JE; Division of Infection Diseases, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Firstenberg MS; Department of Surgery, Maui Memorial Medical Center, Maui, HI, USA., Rhys-Williams W; Destiny Pharma plc, Brighton, UK., Lees JP; Formerly at Destiny Pharma plc, Brighton, UK., Dane A; Danestat Consulting Ltd., Macclesfield, UK., Love WG; Destiny Pharma plc, Brighton, UK., Gonzalez Moreno J; Formerly at Destiny Pharma plc, Brighton, UK., Martina Y; Formerly at Destiny Pharma plc, Brighton, UK., Barker D; Destiny Pharma plc, Brighton, UK. |
| Source: | Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2024 Nov; Vol. 45 (11), pp. 1355-1357. Date of Electronic Publication: 2024 Oct 10. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Cambridge University Press Country of Publication: United States NLM ID: 8804099 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-6834 (Electronic) Linking ISSN: 0899823X NLM ISO Abbreviation: Infect Control Hosp Epidemiol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1559-6834 |
|---|---|
| DOI: | 10.1017/ice.2024.122 |
